Algert Global LLC Boosts Stake in Balchem Co. (NASDAQ:BCPC)

Algert Global LLC lifted its holdings in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 72.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,421 shares of the basic materials company's stock after acquiring an additional 3,951 shares during the period. Algert Global LLC's holdings in Balchem were worth $1,450,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Envestnet Portfolio Solutions Inc. lifted its stake in Balchem by 1.5% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 3,926 shares of the basic materials company's stock valued at $604,000 after acquiring an additional 59 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Balchem by 18.0% during the first quarter. GAMMA Investing LLC now owns 473 shares of the basic materials company's stock worth $73,000 after purchasing an additional 72 shares during the last quarter. Hsbc Holdings PLC boosted its holdings in Balchem by 1.5% during the second quarter. Hsbc Holdings PLC now owns 4,915 shares of the basic materials company's stock worth $757,000 after purchasing an additional 75 shares during the last quarter. Xponance Inc. increased its stake in Balchem by 5.2% in the 2nd quarter. Xponance Inc. now owns 2,046 shares of the basic materials company's stock valued at $315,000 after buying an additional 102 shares during the last quarter. Finally, Pitcairn Co. lifted its position in shares of Balchem by 3.6% during the 1st quarter. Pitcairn Co. now owns 3,315 shares of the basic materials company's stock worth $514,000 after buying an additional 115 shares in the last quarter. 87.91% of the stock is owned by institutional investors.

Balchem Stock Performance

BCPC stock traded up $1.28 during mid-day trading on Friday, hitting $172.25. The company had a trading volume of 62,558 shares, compared to its average volume of 107,421. Balchem Co. has a 12 month low of $110.74 and a 12 month high of $186.03. The stock's fifty day moving average price is $171.45 and its two-hundred day moving average price is $160.41. The firm has a market cap of $5.58 billion, a PE ratio of 48.59, a price-to-earnings-growth ratio of 5.54 and a beta of 0.65. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.79 and a current ratio of 2.83.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its quarterly earnings data on Friday, July 26th. The basic materials company reported $0.98 EPS for the quarter, beating the consensus estimate of $0.95 by $0.03. Balchem had a return on equity of 10.94% and a net margin of 12.52%. The business had revenue of $234.08 million for the quarter, compared to the consensus estimate of $241.26 million. On average, analysts forecast that Balchem Co. will post 3.96 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on BCPC shares. HC Wainwright boosted their target price on Balchem from $170.00 to $185.00 and gave the stock a "buy" rating in a research note on Wednesday, July 31st. StockNews.com lowered Balchem from a "buy" rating to a "hold" rating in a research report on Monday, July 29th.

Insider Activity

In related news, SVP Gunsteren Job Leonard Van sold 7,750 shares of the business's stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $180.05, for a total value of $1,395,387.50. Following the sale, the senior vice president now directly owns 8,540 shares in the company, valued at approximately $1,537,627. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 1.25% of the company's stock.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.